Cargando…
Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series
Juvenile dermatomyositis (JDM) has a wide spectrum of clinical presentations. In the last decade, several myositis-specific antibodies have been identified in patients with JDM and connected with specific organ involvement or specific clinical picture. It has been published that the presence of anti...
Autores principales: | Toplak, Natasa, Pimpale Chavan, Pallavi, Rosina, Silvia, Dallos, Tomas, Rotem Semo, Oz, Aguiar, Cassyanne L., Khubchandani, Raju, Ravelli, Angelo, Patwardhan, Anjali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904416/ https://www.ncbi.nlm.nih.gov/pubmed/35280444 http://dx.doi.org/10.3389/fped.2021.810785 |
Ejemplares similares
-
Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
por: Tansley, Sarah L., et al.
Publicado: (2014) -
Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody
por: Gossez, Morgane, et al.
Publicado: (2015) -
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis
por: Ceribelli, Angela, et al.
Publicado: (2012) -
A rare case of NXP-2 positive dermatomyositis
por: Khan, Nariman, et al.
Publicado: (2021) -
NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation
por: Butt, Zeeshan, et al.
Publicado: (2017)